Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Oncology 9 (2019): 1361.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2019
- Creator
-
Zhou, Jian-Guo
Liang, Bo
Jin, Su-Han
Liao, Hui-Ling
Du, Guo-Bo
Cheng, Long
Ma, Hu
Gaipl, Udo S.
- DOI
-
10.3389/fonc.2019.01361
- URN
-
urn:nbn:de:bvb:29-opus4-127191
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Jian-Guo
- Liang, Bo
- Jin, Su-Han
- Liao, Hui-Ling
- Du, Guo-Bo
- Cheng, Long
- Ma, Hu
- Gaipl, Udo S.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2019
Other Objects (12)
Validation and functional characterization of a prognostic 4-miRNA signature in Glioblastoma
Construction and validation of gene signature-based prognostic models for patients with urological cancers
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
A prognostic neural epigenetic signature in high-grade glioma
Hypoxia-Immune-Related Microenvironment as Prognostic Signature for Osteosarcoma
Identification and characterization of genetic alterations in neuroblastoma and their prognostic relevance
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Identification of a novel tumor microenvironment prognostic signature for advanced-stage serous ovarian cancer
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression
Validation and functional characterization of a prognostic 4-miRNA signature in Glioblastoma
Construction and validation of gene signature-based prognostic models for patients with urological cancers
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
A prognostic neural epigenetic signature in high-grade glioma
Hypoxia-Immune-Related Microenvironment as Prognostic Signature for Osteosarcoma
Identification and characterization of genetic alterations in neuroblastoma and their prognostic relevance
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Identification of a novel tumor microenvironment prognostic signature for advanced-stage serous ovarian cancer
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression
Validation and functional characterization of a prognostic 4-miRNA signature in Glioblastoma
Construction and validation of gene signature-based prognostic models for patients with urological cancers
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
A prognostic neural epigenetic signature in high-grade glioma
Hypoxia-Immune-Related Microenvironment as Prognostic Signature for Osteosarcoma
Identification and characterization of genetic alterations in neuroblastoma and their prognostic relevance
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Identification of a novel tumor microenvironment prognostic signature for advanced-stage serous ovarian cancer